FLAK97

General Information


DRACP ID  DRACP01697

Peptide Name   FLAK97

Sequence  FALKALKK

Sequence Length  8

UniProt ID  Not available

PubChem CID  Not available

Origin  FLAK peptides

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma LD50=1000 µg/ml MTT assay 24 h Patent
SW480 Colon adenocarcinoma Carcinoma LD50=1000 µg/ml MTT assay 24 h Patent
BMKC Skin carcinoma Carcinoma LD50=1000 µg/ml MTT assay 24 h Patent
BMKC Skin carcinoma Carcinoma LD50=1000 µg/ml MTT assay 24 h Patent
NCI-H1299 Lung large cell carcinoma Carcinoma LD50=1000 µg/ml MTT assay 24 h Patent
PC-3 Prostate carcinoma Carcinoma LD50=1000 µg/ml MTT assay 24 h Patent
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma LD50=240 µg/ml MTT assay 24 h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01697

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C45H79N11O9

Absent amino acids  CDEGHIMNPQRSTVWY

Common amino acids  K

Mass  104324

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  5

Net charge  3

Boman Index  -21

Hydrophobicity  28.75

Aliphatic Index  122.5

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US2005/0209157A1

Patent Title  Short bioactive peptides and methods for their use

Other Iinformation  Patent Application; Family: 1s / 24ex; Family Jurisdictions: US; Legal Status: Discontinued; Application No: 13618605; Filed: May 24, 2005; Published: Sep 22, 2005; Earliest Priority: Mar 28, 2001

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.